Market revenue in 2023 | USD 5,673.9 million |
Market revenue in 2030 | USD 10,234.5 million |
Growth rate | 8.8% (CAGR from 2023 to 2030) |
Largest segment | Outsourcing |
Fastest growing segment | Outsourcing |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | In-house, Outsourcing |
Key market players worldwide | Genpact Ltd, Criterium Inc., Icon PLC, Wuxi AppTec Co Ltd, Medpace Holdings Inc, Charles River Laboratories International Inc, Labcorp Holdings Inc, FREYR Battery Inc, Pharmexon, Cambridge Design Partnership, Voisin Consulting Life Sciences, Accell, PAREXEL, Promedica International, PharmaLex, NDA Regulatory Service GmbH, QVigilance, BlueReg Group |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to regulatory affairs market will help companies and investors design strategic landscapes.
Outsourcing was the largest segment with a revenue share of 58.15% in 2023. Horizon Databook has segmented the Asia Pacific regulatory affairs market based on in-house, outsourcing covering the revenue growth of each sub-segment from 2018 to 2030.
Asia Pacific is expected to be the largest market for Regulatory affairs market during the forecast period owing to the improved regulatory landscape, cost savings, growing number of clinical trials conducted in the region, and increasing number of biopharmaceutical companies venturing in the region.
Furthermore, availability of skilled workforce within the region at a lower cost compared to the U.S. is another factor expected to propel growth. According to a report by Deloitte, Asia Pacific accounts for 60.0% of the world’s population.
This is anticipated to increase the number of market entrants, thereby raising the need for regulatory services. Rising demand for biosimilars and medical devices is also expected to contribute to the growth of biopharmaceutical and medical devices market within the region.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific regulatory affairs market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific regulatory affairs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account